A scope you can put a budget and a date against.
Pharmaceutical project scoping for companies who need a real number before they can get budget approved: a discovery phase that turns a vague brief into requirements, architecture and an estimate that holds once the project starts.
Pharmaceutical projects are harder to estimate blind than most, because the real complexity is usually not visible in the brief: how many markets, what regulatory content has to be preserved, which systems have to be integrated. Estimating without discovery means guessing, and the guess is usually wrong in the expensive direction.
Stakeholder interviews, a reviewed content and system inventory, a defined architecture, and a detailed estimate broken down by workstream rather than a single number.
Scoping is a paid phase, stated upfront, and if you proceed with us it is credited against the build, so the discovery work counts toward the project rather than being sunk cost either way.
What pharmaceutical project scoping routinely surfaces before a build starts.
The brief that arrives is rarely the real requirement. Pharmaceutical project scoping exists to find the difference.
What companies ask before committing to a discovery phase.
No, and we are upfront about that from the first conversation, rather than disguising a sales exercise as free discovery work. It is a paid phase with its own concrete deliverable, and we credit the full cost against the build if you choose to proceed with us afterward.
Yes, the scope belongs to you once it is delivered, not to us. The requirements, information architecture and cost estimate are documented in a form any competent team can pick up and build from, including an agency that is not us. We would rather earn the build on the strength of the scoping work than make the deliverable unusable elsewhere as a way of securing the project.
It depends on the complexity uncovered rather than the length of the brief. A straightforward corporate site is scoped quickly; a project touching several markets, systems and audiences takes longer, and we would rather tell you that upfront than compress it artificially.
It should not, materially, if the scoping was done properly. That is the point of the phase: reducing the gap between the estimate and what the project costs, which is where budget overruns come from on projects that skipped discovery.
Scoping is usually the first phase of a larger build. These are the services the estimate typically covers.
A brief that needs a real number before budget can be approved. Tell us what you have and we will tell you how we would approach the pharmaceutical project scoping.